Incidence of inflammatory bowel disease in the French West Indies (1997-1999)

被引:21
作者
Edouard, A [1 ]
Paillaud, M
Merle, S
Orhan, C
Chenayer-Panelatti, M
le Cogeag
机构
[1] CHU Fort France, Serv Hepatogastroenterol, BP 632, F-97261 Fort De France, Martinique, France
[2] Ctr Med Social, F-97100 Basse Terre, Guadeloupe, France
[3] CHU Fort France, Observ Reg Sante Martinique, F-97261 Fort De France, Martinique, France
[4] CHU Fort France, Serv Med Interne, F-97261 Fort De France, Martinique, France
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2005年 / 29卷 / 8-9期
关键词
D O I
10.1016/S0399-8320(05)86347-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives - To investigate the incidence of inflammatory bowel disease in the French West Indies. Methods - From January 1 1997 to December 31 " 1999 all patients observed with clinical symptoms suggestive of inflammatory bowel disease attending gastroenterologists practicing in Guadeloupe and Martinique were included. Patients were interviewed with a standard questionnaire to record data used by an expert to establish the final diagnosis of definite, probable or possible Crohn's disease, ulcerative colitis, unclassifiable chronic colitis or acute colitis, according to the EPIMAD registry. Results - Sixty-six cases of ulcerative colitis (47.48%) including 12 cases of ulcerative proctitis (18.18% of the ulcerative colitis cohort), 55 of Crohn's disease (39.57%), 11 of unclassifiable chronic colitis (7.91%), and 7 of acute colitis (5.04%) were recorded. The crude annual incidence (per 100,000 inhabitants) based on definite and probable cases only was 2.44 for ulcerative colitis and 1.94 for Crohn's disease. The female/male ratio and median age at time of diagnosis were 1.61 and 29 years for Crohn's disease and 1.46 and 34 years for ulcerative colitis respectively. The median time from symptom onset to diagnosis was 2 months for both diseases. Conclusions - The observed incidence of inflammatory bowel disease In the French West-Indies is lower than in metropolitan France. These data will serve as a basis to assess disease evolution.
引用
收藏
页码:779 / 783
页数:5
相关论文
共 28 条
[11]   INCIDENCE OF INFLAMMATORY BOWEL-DISEASE IN NORTHERN FRANCE (1988-1990) [J].
GOWERROUSSEAU, C ;
SALOMEZ, JL ;
DUPAS, JL ;
MARTI, R ;
NUTTENS, MC ;
VOTTE, A ;
LEMAHIEU, M ;
LEMAIRE, B ;
COLOMBEL, JF ;
CORTOT, A .
GUT, 1994, 35 (10) :1433-1438
[12]  
GowerRousseau C, 1997, GASTROEN CLIN BIOL, V21, P481
[13]   Review article: helminths as therapeutic agents for inflammatory bowel disease [J].
Hunter, MM ;
Mckay, DM .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (02) :167-177
[14]   Inflammatory bowel disease and environmental influences [J].
Krishnan, A ;
Korzenik, JR .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (01) :21-+
[15]  
LEE MG, 1988, W INDIAN MED J, V37, P205
[16]  
Lerebours E, 2003, GASTROEN CLIN BIOL, V27, pS76
[17]   Epidemiology of inflammatory bowel disease [J].
Loftus, EV ;
Sandborn, WJ .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (01) :1-+
[18]   INFLAMMATORY BOWEL-DISEASE IN RURAL SUB-SAHARAN AFRICA - RARITY OF DIAGNOSIS IN PATIENTS ATTENDING MISSION HOSPITALS [J].
MAYBERRY, J ;
MANN, R .
DIGESTION, 1989, 44 (03) :172-176
[19]  
MOREAU J, 2000, GUT, V47, pA225
[20]  
Moreno J M, 1989, Bol Asoc Med P R, V81, P214